Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 557-564 , July 2010

Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia

  • Vamsidhar Akurathi

      Affiliations

    • Laboratory for Radiopharmacy, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
    • ,
  • Ludwig Dubois

      Affiliations

    • Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, University of Maastricht, 6200 Maastricht, The Netherland
    • ,
  • Natasja G. Lieuwes

      Affiliations

    • Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, University of Maastricht, 6200 Maastricht, The Netherland
    • ,
  • Satish K. Chitneni

      Affiliations

    • Department of Radiology, Duke University Medical Centre, Durham, NC 27710, USA
    • ,
  • Bernard J. Cleynhens

      Affiliations

    • Laboratory for Radiopharmacy, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
    • ,
  • Daniela Vullo

      Affiliations

    • Universita degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica, 50019 Sesto Fiorentino, Florence, Italy
    • ,
  • Claudiu T. Supuran

      Affiliations

    • Universita degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica, 50019 Sesto Fiorentino, Florence, Italy
    • ,
  • Alfons M. Verbruggen

      Affiliations

    • Laboratory for Radiopharmacy, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
    • ,
  • Philippe Lambin

      Affiliations

    • Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, University of Maastricht, 6200 Maastricht, The Netherland
    • ,
  • Guy M. Bormans

      Affiliations

    • Laboratory for Radiopharmacy, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
    • Corresponding Author InformationCorresponding author. Post box 821, O&N2, Herestraat 49, BE-3000 Leuven, Belgium. Tel.: +32 0 16 330447; fax: +32 0 16 330449.

Received 26 October 2009 ,Revised 23 February 2010 ,Accepted 28 February 2010.

References 

  1. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 2008;11:851–864
  2. Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: An integrated view. Curr Mol Med. 2003;3:659–671
  3. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia and cancer. J Mol Med. 2007;85:1301–1307
  4. Pennacchietti S, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 2003;3:347–361
  5. Harris AL. Hypoxia a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38–47
  6. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996;56:941–943
  7. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res. 1996;56:5754–5757
  8. Pastorekova S, Pastorek J. C R C enzymes inhibitors series. In:  Supuran CT,  Scozzafava A,  Conway J editor. Carbonic anhydrase—its inhibitors and activators. London: C R.C. Press; 2005;p. 255–281
  9. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem. 2004;19:199–229
  10. Stubbs M, McSheehy PMJ, Griffiths JR, Bashford CL. Causes and consequences of tumor acidity and implications for treatment. Mol Med Today. 2000;6:15–19
  11. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res. 2000;8:1284–1291
  12. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, Jain RK. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res. 2001;61:6020–6024
  13. Martinez-Zaguilan R, Lynch RM, Martinez GM, Gillies RJ. Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis. 1992;14:176–186
  14. Fischer B, Muller B, Fischer KG, Baur N, Kreutz W. Acidic pH inhibits non-MHC-restricted killer cell functions. Clin.Immunol. 2000;96:252–263
  15. Dubois L, Douma K, Supuran CT, Chiu RK, van Zandvoort MA, Pastorekova S, et al. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. Radiother Oncol. 2007;83:367–373
  16. Chrastina A, Zavada J, Parkkila S, Kaluz T, Kaluzova M, Rajcani J, et al. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma. Int J Cancer. 2003;105:873–881
  17. Stillebroer AB, Oosterwijk E, Oyen WJG, Mulders PFA, Boerman OC. Radiolabeled antibodies in renal cell carcinoma. Cancer Imaging. 2007;7:179–188
  18. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discovery. 2008;7:168–181
  19. Svastova E, Hulikova A, Rafajova M, Zatovicova M, Gibadulinova A, Casini A, et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004;577:439–445
  20. Casey JR, Morgan PE, Vullo D, Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J Med Chem. 2004;47:2337–2347
  21. Jonathan RD, Suzanne JP. The biomedical chemistry of technetium and rhenium. Chem Soc Rev. 1998;27:43–55
  22. Kieffer D, Cleynhens B, Vanbilloen H, Rattat D, Terwinghe C, Mortelmans L, et al. Synthesis and biological evaluation of a technetium-99m(I)-tricarbonyl-labelled phenyltropane derivative. Bioorg Med Chem Lett. 2006;16:382–386
  23. Rattat D, Cleynhens B, Bormans G, Terwinghe C, Verbruggen A. Characterisation and biodistribution of two neutral 99mTc(CO)3 complexes with a tridentate ligand. Bioorg Med Chem Lett. 2005;15:4192–4195
  24. Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, Pastorekova S, et al. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 2003;13:1005–1009
  25. Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastorekova S, et al. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs. Bioorg Med Chem Lett. 2005;15:963–969
  26. Tzanopoulou S, Pirmettis IC, Patsis G, Paravatou-Petsotas M, Livaniou E, Papadopoulos M, et al. Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M=Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem. 2006;49:5408–5410
  27. Vanbilloen HP, Kieffer D, Cleynhens B, Bormans G, Mortelmans L, Verbruggen A. Development and biological evaluation of 99mTc-BAT-tropane esters. Nucl Med Biol. 2005;32:607–612
  28. Khalifah RGT. The carbon dioxide hydration activity of carbonic anhydrase. J. Biol. Chem. 1971;246(8):2561–2573
  29. Singh J, Wyeth P. The enzyme inhibitor approach to cell selective labeling sulfonamide inhibitor. Sulfonamid inhibitors of carbonic anhydrase as carriers for red cell labeling in vitro uptake of PIBS by human red blood cells. Appl. Radiat. Isot. 1991;42:251–259
  30. Yamazaki M, Akiyama S, Nishigaki R, Sugiyama Y. Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady state in rats.. Pharm Res. 1996;10:1559–1564
  31. Shin KH, Diaz-Gonzalez JA, Russell J, Chen Q, Burgman P, Li XF, et al. Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole. Cancer Biol Ther. 2007;6:70–75
  32. Purkerson JM, Schwartz GJ. The role of carbonic anhydrases in renal physiology. Kidney Int. 2007;71:103–115
  33. Pastorekova S, Parkkila S, Zavada J. Tumor associated carbonic anhydrases and their clinical significance. Advances in clinical chemistry. 2006;42:167–216
  34. Bussink J, Kaanders JHAM, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol. 2003;67:3–15

PII: S0969-8051(10)00031-4

doi: 10.1016/j.nucmedbio.2010.02.006

Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 557-564 , July 2010

Article Tools

* Image Usage & Resolution